Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company (Both Standalone And Consolidated) For The Quarter Ended 30Th September, 2018.

• Security Code: 524404
• Company: MARKSANS

MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2018 ,inter alia, to consider and approve This is to inform you that the Meeting of the Board of Directors of the Company will be held on Tuesday, 13th November, 2018 at Mumbai, to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the quarter ended 30th September, 2018.

Please note that as per the Insider Trading Code of the Company, the Trading Window for dealing in Company's shares will remain closed for the Company's insiders from today i.e. 1st November, 2018 (Commencing from the time of above intimation to the Stock Exchanges) till Forty-Eight hours after the announcement of the Unaudited Financial Results on 13th November, 2018.